SuperSonic Imagine – Availability of the information relating to the Ordinary Shareholders’ Meeting of October 30, 2020
09 Octobre 2020 - 6:00PM
Business Wire
Regulatory News:
SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814,
PEA-PME eligible), which specializes in ultrasound medical imaging,
hereby informs shareholders of the availability of the preparatory
documents related to the Ordinary Shareholders' Meeting to be held
in closed session (huis clos) on Friday, October 30, 2020 at 9 a.m.
at the Company's headquarters (510, rue René Descartes - 13857
Aix-en-Provence).
As a reminder (see press release dated September 23, 2020), in
the context of the Coronavirus (Covid-19) epidemic and in
accordance with the provisions of order n° 2020-321 of March 25,
2020 taken within the framework of the authorization granted by the
emergency law to face the Covid-19 epidemic n° 2020-290 of March
23, 2020, whose application was extended until November 30, 2020 by
decree n° 2020-925 of July 29, 2020, the Board of Directors of
SuperSonic Imagine decided, at its meeting of September 22, 2020,
that the Ordinary Shareholders' Meeting of October 30, 2020 will
exceptionally be held in closed session, without the shareholders
being present (either physically or by telephone or audiovisual
conference). The procedures for participation and organization of
this Ordinary Shareholders' Meeting have been adapted
accordingly.
The meeting notice being considered as a convening notice which
includes the agenda, the full text of the draft resolutions
proposed by the Board of Directors to the shareholders' vote, as
well as the main terms and conditions for participating and voting
at the Ordinary Shareholders' Meeting, was published in the
official bulletin of legal annoucements (BALO) on September 23,
2020 (Bulletin No. 115 - Announcement 2004099). This meeting notice
being considered as a convening notice is available on the
SuperSonic Imagine website (https://www.supersonicimagine.fr -
Investors > Documentation > Shareholders Meeting).
The preparatory documents and information for the Ordinary
Shareholders' Meeting are made available to SuperSonic Imagine's
shareholders in accordance with applicable legal and regulatory
provisions (including Order N° 2020-321 of March 25, 2020).
These documents may be sent upon request by email to the
following address: supersonicimagine@newcap.eu. The communication
of any information or document will be validly made by e-mail
provided that the shareholder indicates in his/her request the
e-mail address to which it can be sent. Shareholders are therefore
encouraged to provide their e-mail address when submitting any
request.
All the preparatory documents for the Ordinary Shareholders'
Meeting referred to in Article R. 225-73-1 of the French Commercial
Code are online on the SuperSonic Imagine website
(https://www.supersonicimagine.fr - Investors > Documentation
> Shareholders' Meetings).
Given the context, shareholders are invited to regularly consult
the section dedicated to the Ordinary General Meeting on SuperSonic
Imagine website and/or to send any questions concerning the holding
of the Ordinary Shareholders Meeting to the following address:
supersonicimagine@newcap.eu.
About SuperSonic Imagine SuperSonic Imagine is a medical
technology company (Medtech) specialized in ultrasound imaging. The
company designs, develops and markets an ultrasound platform whose
exclusive ultrafast technology (UltraFast™) has given rise to new
imaging methods, which have now become standards in the
non-invasive care path for the characterization of breast, liver or
prostate diseases. The first innovative mode UltraFast™ is
ShearWave® elastography (SWE™), which allows doctors to instantly
visualize and analyze tissue hardness, which is critical
information for the diagnosis of many pathologies. To date, more
than 600 publications have validated the benefits of its
technologies. The latest addition to the Aixplorer® range,
Aixplorer MACH® 30 introduces a new generation of imaging
UltraFast™ allowing the optimization of all innovative imaging
modes: ShearWave PLUS, UltraFast Doppler, Angio PL.U.S, TriVu. With
almost 2,800 ultrasound platforms installed worldwide, SuperSonic
Imagine is present in more than 80 countries and its main markets
are China, the United States and France. The group's revenues for
the 2019 financial year amounted to €26.4 million. SuperSonic
Imagine is a company listed on Euronext (symbol: SSI). For more
information, visit www.supersonicimagine.fr.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201009005333/en/
Contacts – Investor Relations NewCap Thomas Grojean
supersonicimagine@newcap.eu +33 44 71 94 94